Sanlayan, Klea .

HRN: 19-83-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFTRIAXONE 1G (VIAL)
12/26/2022
01/02/2023
IV
1G
Q24
T/C UTI
Waiting Final Action 
12/29/2022
MUPIROCIN 2%, 15G (TUBE)
12/29/2022
01/04/2023
TOPICAL
Small Amount
TID
T/c Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: